Monitoring Combretastatin A4–induced tumor hypoxia and hemodynamic changes using endogenous MR contrast and DCE‐MRI-Reference-Cited by-同舟云学术

Monitoring Combretastatin A4–induced tumor hypoxia and hemodynamic changes using endogenous MR contrast and DCE‐MRI

Published:2015-03-12 Issue:2 Volume:75 Page:866-872
ISSN:0740-3194
Container-title:Magnetic Resonance in Medicine
language:en
Short-container-title:Magn. Reson. Med.

Author:

Colliez Florence¹,Fruytier Anne‐Catherine¹,Magat Julie¹,Neveu Marie‐Aline¹,Cani Patrice D.²,Gallez Bernard¹,Jordan Bénédicte F.¹

Affiliation:

1. Université Catholique de Louvain, Louvain Drug Research InstituteBiomedical Magnetic Resonance GroupAvenue Mounier 73B1.73.08 Brussels Belgium

2. Université Catholique de Louvain, Louvain Drug Research Institute, Metabolism and Nutrition Research GroupAvenue Mounier 73B1.73.08 Brussels Belgium

Funder

FRS-FNRS, the Télévie fund, and Fondation Fournier-Majoie

histological analysis and Alexandre Barrois for assistance with lipid content assessment

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mrm.25642

Reference40 articles.

1. A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment

2. Disrupting tumour blood vessels

3. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure‐activity study;Lin CM;Mol Pharmacol,1988

4. Characterizing the Tumor Response to Treatment With Combretastatin A4 Phosphate

5. Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel approach for dose painting radiotherapy of brain metastases guided by mr perfusion images;Frontiers in Oncology;2022-12-01

2. Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment;Cancers;2021-09-24

3. Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity;European Journal of Medicinal Chemistry Reports;2021-07

4. Oxygenation Status in Normal Tissues, Pathological Tissues and Malignant Tumors: A pO2 Database Based on Electron Paramagnetic Resonance (EPR) Oximetry Measurements;Applied Magnetic Resonance;2021-06-11

5. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors;Molecules;2021-04-27